Analysts Point To Bicycle Therapeutics Plc ADR (NASDAQ: BCYC) Growth In The Future

After Hours

There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities.

Stocks Info

As a NASDAQ listed company, BCYC falls under the Healthcare sector while operating within the Biotechnology industry segment. The current market capitalization of Bicycle Therapeutics Plc ADR is $511.07M. A total of 0.54 million shares were traded on the day, compared to an average of 279.73K shares.

In the most recent transaction, Lee Kevin sold 3,193 shares of BCYC for 7.44 per share on Jul 03 ’25. After the transaction, the CHIEF EXECUTIVE OFFICER now owns 480,804 company shares. In a previous transaction on Jul 02 ’25, Lee Kevin sold 2,268 shares at 7.09 per share. BCYC shares that CHIEF EXECUTIVE OFFICER owns now total 483,997.

Among the insiders who sold shares, Skynner Michael disposed of 966 shares on Jul 03 ’25 at a per-share price of $7.44. This resulted in the CHIEF TECHNOLOGY OFFICER holding 120,079 shares of BCYC after the transaction. In another insider transaction, Skynner Michael sold 825 shares at $7.09 per share on Jul 02 ’25. Company shares held by the CHIEF TECHNOLOGY OFFICER now total 121,045.

In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. In terms of 52-week highs and lows, BCYC has a high of $28.67 and a low of $6.10.

Balance Sheet Annually/Quarterly

The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. BCYC’s latest balance sheet shows that the firm has $438.68M in Cash & Short Term Investments as of fiscal 2021. There were $44.34M in debt and $36.24M in liabilities at the time. Its Book Value Per Share was $9.66, while its Total Shareholder’s Equity was $346.25M.

Analysts Opinion

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for BCYC is Buy with a score of 4.38.

Related Posts

Park Telegraph
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.